Literature DB >> 810575

Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion.

R G Blasberg, C Patlak, J D Fenstermacher.   

Abstract

Ventriculocisternal perfusions with five isotopically labeled drugs were performed in the rhesus monkey and the resultant tissue diffusion concentration profiles in caudate nucleus were analyzed. The periventricular distribution space with respect to perfusate concentration was measured and expressed as microliters per 100 mg wet weight: hydroxyurea = 56; methotrexate = 27; thiotepa = 28; 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) = 64 and cytosine arabinoside greater than 170. The apparent diffusion constants in caudate nucleus were determined for hydroxyurea and methotrexate (2.0 and 1.2 X 10(-6) cm2/sec, respectively); capillary permeability expressed as an extracellular space-transcapillary exchange half-time was estimated to be greater than 2 hours for both compounds. The extracellular fluid-transcapillary half-time was measured for thiotepa and BCNU (1.0 and 0.8 minute, respectively). Cytosine arabinoside continued to be concentrated by periventricular caudate nucleus during the course of perfusion; perfusate clearance measurements suggest a low capillary permeability. The apparent parenchymal diffusion constant and the capillary permeability of a drug in brain are discussed and are considered useful parameters for predicting drug levels after intrathecal administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810575

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  94 in total

Review 1.  Permeable endothelium and the interstitial space of brain.

Authors:  M W Brightman; M Kaya
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  Intrathecal chemotherapy with antineoplastic agents in children.

Authors:  A Ruggiero; V Conter; M Milani; E Biagi; I Lazzareschi; P Sparano; R Riccardi
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Ultrasound-enhanced drug transport and distribution in the brain.

Authors:  Ying Liu; Sumit Paliwal; Krystof S Bankiewicz; John R Bringas; Gill Heart; Samir Mitragotri; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

Review 4.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Intrathecal drug administration. Present use and future trends.

Authors:  J S Kroin
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 6.  Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.

Authors:  Iason T Papademetriou; Tyrone Porter
Journal:  Ther Deliv       Date:  2015-08-25

Review 7.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 8.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

9.  Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.

Authors:  T Y Huang; N Arita; Y Ushio; T Hayakawa; K Yamada
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model.

Authors:  J Pollina; R J Plunkett; M J Ciesielski; A Lis; T A Barone; S J Greenberg; R A Fenstermaker
Journal:  J Neurooncol       Date:  1998-09       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.